X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
middle aged (5) 5
breast cancer (4) 4
female (4) 4
index medicus (4) 4
adult (3) 3
aged (3) 3
breast neoplasms - drug therapy (3) 3
cancer (3) 3
chemotherapy (3) 3
clinical trials (3) 3
dose-response relationship, drug (3) 3
tumor cells, cultured (3) 3
adenocarcinoma - immunology (2) 2
adenocarcinoma - metabolism (2) 2
antibodies, monoclonal (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer patients (2) 2
care and treatment (2) 2
chemotherapy, adjuvant (2) 2
correction (2) 2
culture media, conditioned - pharmacology (2) 2
cyclophosphamide - adverse effects (2) 2
epirubicin - adverse effects (2) 2
fluorouracil - adverse effects (2) 2
immunophenotyping (2) 2
interferon-gamma - antagonists & inhibitors (2) 2
interleukin-10 - biosynthesis (2) 2
interleukin-10 - blood (2) 2
interleukin-10 - metabolism (2) 2
interleukin-12 - antagonists & inhibitors (2) 2
killer cells, lymphokine-activated - immunology (2) 2
male (2) 2
oncology (2) 2
pancreatic ducts - pathology (2) 2
pancreatic neoplasms - immunology (2) 2
pancreatic neoplasms - metabolism (2) 2
regular (2) 2
reverse transcriptase polymerase chain reaction (2) 2
t-lymphocytes - immunology (2) 2
th1 cells - immunology (2) 2
th2 cells - immunology (2) 2
transforming growth factor beta - biosynthesis (2) 2
transforming growth factor beta - blood (2) 2
transforming growth factor beta - metabolism (2) 2
tumors (2) 2
abridged index medicus (1) 1
adenocarcinoma cells (1) 1
adjuvant treatment (1) 1
adolescent (1) 1
advanced breast cancer (1) 1
advanced breast cancer; elderly; everolimus; exemestane; hormone-receptor positive; oncology (1) 1
amenorrhea (1) 1
amenorrhea - chemically induced (1) 1
analysis (1) 1
animals (1) 1
anthracycline (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
bone marrow - physiology (1) 1
bone marrow cells (1) 1
breast (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - pathology (1) 1
breast neoplasms - surgery (1) 1
cancer therapies (1) 1
cell suppressor factor (1) 1
cells (1) 1
choice (1) 1
clinical study (1) 1
coculture techniques (1) 1
confidence intervals (1) 1
consensus (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
cyclophosphamide - therapeutic use (1) 1
cytokine production (1) 1
denosumab (1) 1
disease-free survival (1) 1
dose-dense chemotherapy (1) 1
drug administration schedule (1) 1
drug dosages (1) 1
e7389 (1) 1
efficacy (1) 1
elderly (1) 1
epidemiology (1) 1
epirubicin (1) 1
epirubicin - administration & dosage (1) 1
epirubicin - therapeutic use (1) 1
eribulin (1) 1
erythropoiesis - physiology (1) 1
everolimus (1) 1
exemestane (1) 1
fertility concerns (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - therapeutic use (1) 1
furans - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1863 - 1872
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 71, pp. 34 - 42
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 1999, Volume 155, Issue 2, pp. 537 - 547
In this study, we report coexpression of transforming growth factor-β (TGF-β) and interleukin-10 (IL-10) in pancreatic carcinoma tissue associated with... 
TGF-BETA | CYTOKINE PRODUCTION | KILLER-CELLS | ADENOCARCINOMA CELLS | MELANOMA-CELLS | MALIGNANT-MELANOMA | PATHOLOGY | CELL SUPPRESSOR FACTOR | HUMAN BREAST-CANCER | T-CELLS | GLIOBLASTOMA CELLS
Journal Article
International journal of cancer, ISSN 0020-7136, 11/2019
Dose-dense adjuvant chemotherapy is standard of care in high-risk early breast cancer patients. However, its role in HER2-positive patients is still uncertain.... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e12561 - e12561
e12561 Background: Metastatic breast cancer (MBC) is an incurable disease. The main goals of treatment are palliation, symptoms control, preserving QoL and... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12528 - e12528
e12528 Background: Pts with ABC have a diverse clinical course and OS rates vary significantly among pts. New strategies had potentially changed the natural... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 1057 - 1057
1057 Background: ESO/ESMO recently developed consensus guidelines for MBC treatment, potentially applicable worldwide. Aim of the present analysis is to verify... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 1055 - 1055
1055 Background: The molecular subtypes of BC have individual patterns of behavior, prognosis and sensitivity to treatment, with subsequent implications for... 
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 07/1997, Volume 172, Issue 1, pp. 1 - 11
Activation of the receptor tyrosine kinase c‐kit by the kit‐ligand, also known as stem cell factor (SCF), is essential to melanocyte and germ cell development... 
Journal Article
American Journal of Pathology, ISSN 0002-9440, 08/1999, Volume 155, Issue 2, p. 537
  In this study, we report coexpression of transforming growth factor-beta (TGF-beta) and interleukin-10 (IL-10) in pancreatic carcinoma tissue associated with... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 501 - 501
501 Background: 1-year trastuzumab with chemotherapy is the standard adjuvant treatment for HER2+ breast cancer patients (pts). The efficacy of less extended... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.